MeiraGTx Holdings plc - Ordinary Shares, par value $0.00003881 per share (MGTX)

CUSIP: G59665102

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Ordinary Shares, par value $0.00003881 per share
Total 13F shares
64,273,449
Total 13F value
$419,562,716
Holder snapshot 6 visible 7 signals
Share change
+4,286,403
Put/Call ratio
37%
SEC-reported price per share
$6.52
Number of holders
111
Value change
+$27,529,421
Number of buys
51
Open additional details 1 more signal available
Number of sells
60
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
81,466,395

Security key

G59665102

Report period

Q2 2025

Institutions

111

Top holders

10

MGTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 MeiraGTx Holdings plc SEC filings MeiraGTx Holdings plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MGTX - MeiraGTx Holdings plc - Ordinary Shares, par value $0.00003881 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F 3/4/5 Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership Top 5
PERCEPTIVE ADVISORS LLC 15%
Sanofi 15%
JOHNSON & JOHNSON 8.2%
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.9%
Prosight Management, LP 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
15%
$85,254,892
12,581,103 shares
 — 31 Mar 2025
Sanofi
13F 3/4/5
Company · 10%+ Owner
13F 3/4/5
15%
$82,700,657
12,197,737 shares
 — 31 Mar 2025
JOHNSON & JOHNSON
13F 3/4/5
Company · 10%+ Owner
13F 3/4/5
8.2%
$45,026,414
6,641,064 shares
 — 31 Mar 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
6.9%
$38,202,439
5,634,578 shares
 — 31 Mar 2025
Prosight Management, LP
13F
Company
13F
4.5%
$25,028,682
3,691,546 shares
 — 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
3.8%
$21,210,586
3,128,405 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
111
Shares
64,273,449
Rows available
111
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
118
Q2 2025 holders
111
Holder diff
-7
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .